The addition of the novel drug, BXCL701 to the immunotherapy agent, Keytruda (pembrolizumab) tended to improve survival over Keytruda alone in patients with ...

Patients with advanced/metastatic non–human epidermal growth factor receptor 2 (HER2)-positive gastric/gastroesophageal junction cancer (GC/GEJC) or ...

What advice do you have for researchers interested in making meaningful contributions to the field of cancer prevention and early detection? Dream big. ...

My initial foray into advocacy was born out of the need to shed light on the often-overlooked drawbacks of an oophorectomy I underwent at a young age. This ...

The use of antidepressant medication after receiving a diagnosis of hepatocellular carcinoma (HCC) may be associated with lower overall and cancer-specific ...

A certain gene may be the cause of chemotherapy resistance in some patients with ovarian cancer, according to a recent study.In a study published in Genes ...

There may be a genetic cause to chemotherapy resistance in certain patients with ovarian cancer, research showed.A certain gene may be the cause of ...

Genitourinary oncologists discuss the safety and efficacy of IO/TKI and IO/IO combination therapies in advanced renal cell carcinoma.

Over two million years of life are lost to cancer in the UK every year, according to a new study from Cancer Research UK, published today in the British ...

The phase 3 AMBASSADOR trial (also known as KEYNOTE-123) met its primary endpoint of improved disease-free survival (DFS; time from randomization to ...